Seeking Alpha
Value
Profile| Send Message|
( followers)  

Do you prefer the largest cap stocks? Company liquidity is an important consideration in any stock analysis. Liquidity gives a company the ability to make big acquisitions if it sees investment opportunities, a cushion for future lulls in demand, and most importantly, it keeps a company's doors open. Are these the types of stocks that you're looking for? Do you prefer stocks that analysts rate as 'Buy', or better? If so, you'll probably like this list.

The Current ratio is a liquidity ratio used to determine a company's financial health. The metric illustrates how easily a firm can pay back its short obligations all at once through current assets. A company that has a current ratio of one or less is generally a liquidity red flag. Now this doesn't mean the company will go bankrupt tomorrow, but it also doesn't bode well for the company, and may indicate that it could have an issue paying back upcoming obligations.

The Quick ratio measures a company's ability to use its cash or assets to extinguish its current liabilities immediately. Quick assets include assets that presumably can be converted to cash at close to their book values. A company with a Quick Ratio of less than 1 cannot currently pay back its current liabilities. The quick ratio is more conservative than the Current Ratio because it excludes inventory from current assets, since some companies have difficulty turning their inventory into cash. If short-term obligations need to be paid off immediately, sometimes the current ratio would overestimate a company's short-term financial strength. In general, the higher the ratio, the greater the company's liquidity (i.e., the better able to meet current obligations using liquid assets).

We first looked for large cap stocks. We then looked for companies that have a substantial amount of cash on hand (Current Ratio>2)(Quick Ratio>2). We next screened for businesses that analysts rate as "Buy" or "Strong Buy" (mean recommendation < 3). We did not screen out any sectors.

Do you think these large-cap stocks will break through to new highs? Please use our list to assist with your own analysis.

1) Agilent Technologies Inc. (NYSE:A)

Sector:Technology
Industry:Scientific & Technical Instruments
Market Cap:$14.17B
Beta:1.51

Agilent Technologies Inc. has a Current Ratio of 3.28 and Quick Ratio of 2.76 and Analysts' Rating of 1.50. The short interest was 1.58% as of 05/24/2012. Agilent Technologies, Inc. provides bio-analytical and electronic measurement solutions to the communications, electronics, life sciences, and chemical analysis industries worldwide. Its Electronic Measurement segment offers electronic measurement instruments and systems, and software design tools that are used in the design, development, manufacture, installation, deployment, and operation of electronics equipment and microscopy products. Its products consist of communications and general purpose test products.

2) Analog Devices Inc. (NASDAQ:ADI)

Sector:Technology
Industry:Semiconductor - Integrated Circuits
Market Cap:$10.63B
Beta:1.10

Analog Devices Inc. has a Current Ratio of 8.82 and Quick Ratio of 8.23 and Analysts' Rating of 2.10. The short interest was 1.48% as of 05/24/2012. Analog Devices, Inc. engages in the design, manufacture, and marketing of analog, mixed-signal, and digital signal processing integrated circuits [ICS] used in industrial, automotive, consumer, and communication applications. The company's signal processing products involve in converting, conditioning, and processing real-world phenomena, such as temperature, pressure, sound, light, speed, and motion into electrical signals. Its product range includes data converters, amplifiers and linear products, radio frequency ICs, power management products, sensors based on micro-electro mechanical systems technology and other sensors, and processing products.

3) Broadcom Corp. (NASDAQ:BRCM)

Sector:Technology
Industry:Semiconductor - Integrated Circuits
Market Cap:$17.79B
Beta:1.29

Broadcom Corp. has a Current Ratio of 2.57 and Quick Ratio of 2.17 and Analysts' Rating of 2.00. The short interest was 2.10% as of 05/24/2012. Broadcom Corporation designs and develops semiconductors for wired and wireless communications. It provides a portfolio of system-on-a-chip (SoC) and software solutions for the manufacturers of computing and networking equipment, digital entertainment and broadband access products, and mobile devices, which enable the delivery of voice, video, data, and multimedia content to the home, office, and mobile environment. Its broadband communications products include cable modem SoCs; femtocell SoCs; MPEG/AVC/VC-1 encoders and transcoders; xDSL, passive optical network, and cable modem customer premises equipment and central office solutions; powerline networking SoCs; and digital cable, direct broadcast satellite, terrestrial, and Internet protocol [IP] set-top box integrated receiver demodulators. The company's mobile and wireless products comprise Wi-Fi and Bluetooth SoCs, wireless connectivity combo chips, global positioning system SoCs, multimedia processors, applications processors, power management units, VoIP SoCs, mobile TV SoCs, and near field communications tags.

4) Allergan Inc. (NYSE:AGN)

Sector:Healthcare
Industry:Drug Manufacturers - Other
Market Cap:$27.38B
Beta:0.82

Allergan Inc. has a Current Ratio of 4.38 and Quick Ratio of 4.10 and Analysts' Rating of 2.00. The short interest was 1.28% as of 05/24/2012. Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes specialty pharmaceutical, biologics, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, obesity intervention, urological, and other specialty markets worldwide. It operates in two segments, Specialty Pharmaceuticals and Medical Devices.

5) Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Sector:Healthcare
Industry:Biotechnology
Market Cap:$16.93B
Beta:0.57

Alexion Pharmaceuticals, Inc. has a Current Ratio of 2.30 and Quick Ratio of 2.03 and Analysts' Rating of 1.80. The short interest was 1.62% as of 05/24/2012. Alexion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the innovation, development, and commercialization of life-transforming therapeutic products for treating patients with severe and ultra-rare disorders in the United States, Europe, Latin America, Japan, and the Asia Pacific. It focuses on developing products for the treatment of diseases in the areas of hematology, nephrology, neurology, metabolic disorders, oncology, and ophthalmology. The company offers Soliris(eculizumab), a therapeutic product for the treatment of patients with paroxysmal nocturnal hemoglobinuria [PNH], a blood disorder; and atypical hemolytic uremic syndrome (aHUS), an ultra-rare and life-threatening genetic disease.

6) Altera Corp. (NASDAQ:ALTR)

Sector:Technology
Industry:Semiconductor - Specialized
Market Cap:$10.99B
Beta:1.14

Altera Corp. has a Current Ratio of 4.07 and Quick Ratio of 3.96 and Analysts' Rating of 2.30. The short interest was 1.85% as of 05/24/2012. Altera Corporation, a semiconductor company, designs, manufactures, and markets programmable logic devices (NYSE:PLD), HardCopy application-specific integrated circuit (OTC:ASIC) devices, pre-defined design building blocks, and associated development tools. The company's PLDs consist of field-programmable gate arrays (FPGAs) and complex programmable logic devices (CPLDs), which are standard semiconductor integrated circuits or chips to perform desired logic functions in the electronic systems; and HardCopy structured ASIC devices that comprise transition customer designs from high-density FPGAs to low-cost non-programmable implementations for volume production. Its products primarily include Stratix series high-end, system-level FPGAs; Arria series mid-range transceiver and embedded processor equipped FPGAs; Cyclone series low-cost transceiver and embedded processor equipped FPGAs; MAX series CPLDs; and HardCopy ASICs. The company's products also comprise intellectual property cores in hard and soft forms that are pre-verified building blocks that execute system-level functions; and development tools consisting primarily of the Quartus II software for design entry, design compilation, design verification, and device programming.

7) Becton, Dickinson and Company (NYSE:BDX)

Sector:Healthcare
Industry:Medical Instruments & Supplies
Market Cap:$15.08B
Beta:0.60

Becton, Dickinson and Company has a Current Ratio of 3.27 and Quick Ratio of 2.45 and Analysts' Rating of 2.50. The short interest was 3.93% as of 05/24/2012. Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. This segment's products include needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes, pen needles, and other drugs to treat diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; and closed-system transfer devices.

8) Amgen Inc. (NASDAQ:AMGN)

Sector:Healthcare
Industry:Biotechnology
Market Cap:$53.18B
Beta:0.44

Amgen Inc. has a Current Ratio of 3.24 and Quick Ratio of 2.94 and Analysts' Rating of 2.50. The short interest was 1.84% as of 05/24/2012. Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. The company markets recombinant protein therapeutics in supportive cancer care, nephrology, and inflammation. Its principal products include Aranesp and EPOGEN erythropoietic-stimulating agents that stimulate the production of red blood cells; Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is a type of white blood cell that helps the body to fight infections; and Enbrel, an inhibitor of tumor necrosis factor that plays a role in the body's response to inflammatory diseases.

9) Activision Blizzard, Inc. (NASDAQ:ATVI)

Sector:Technology
Industry:Multimedia & Graphics Software
Market Cap:$13.71B
Beta:0.59

Activision Blizzard, Inc. has a Current Ratio of 2.57 and Quick Ratio of 2.49 and Analysts' Rating of 1.80. The short interest was 6.38% as of 05/24/2012. Activision Blizzard, Inc. publishes online, personal computer (PC), console, handheld, and mobile interactive entertainment worldwide. It develops and publishes PC-based computer games and maintains its proprietary online-game related service, Battle.net.

*Company profiles were sourced from Finviz. Financial data was sourced from Finviz and Yahoo Finance.

Source: 9 Cash-Hoarding Large Cap Stocks With Buy Or Better Ratings